These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8530563)

  • 1. Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique.
    Romano JW; Shurtliff RN; Sarngadharan MG; Pal R
    J Virol Methods; 1995 Aug; 54(2-3):109-19. PubMed ID: 8530563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection.
    Kievits T; van Gemen B; van Strijp D; Schukkink R; Dircks M; Adriaanse H; Malek L; Sooknanan R; Lens P
    J Virol Methods; 1991 Dec; 35(3):273-86. PubMed ID: 1726172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR.
    Vandamme AM; Van Dooren S; Kok W; Goubau P; Fransen K; Kievits T; Schmit JC; De Clercq E; Desmyter J
    J Virol Methods; 1995 Mar; 52(1-2):121-32. PubMed ID: 7769025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays.
    Bruisten S; van Gemen B; Koppelman M; Rasch M; van Strijp D; Schukkink R; Beyer R; Weigel H; Lens P; Huisman H
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):259-65. PubMed ID: 8471317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics.
    Romano JW; Williams KG; Shurtliff RN; Ginocchio C; Kaplan M
    Immunol Invest; 1997; 26(1-2):15-28. PubMed ID: 9037609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
    Winters MA; Holodniy M; Katzenstein DA; Merigan TC
    PCR Methods Appl; 1992 May; 1(4):257-62. PubMed ID: 1477661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HIV-1 RNA in plasma by isothermal amplification (NASBA) irrespective of the stage of HIV-1 infection.
    Zaaijer HL; Kok W; ten Veen JH; Reesink HW; Foolen H; Winkel IN; Huisman JG; Cuypers HT; Kievits T; Lelie PN
    J Virol Methods; 1995 Mar; 52(1-2):175-81. PubMed ID: 7769031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HIV-1 RNA by nucleic acid sequence-based amplification combined with fluorescence correlation spectroscopy.
    Oehlenschläger F; Schwille P; Eigen M
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12811-6. PubMed ID: 8917501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of primary human immunodeficiency virus type 1 isolates: a study of parameters implicated in neutralization in vitro.
    Moog C; Spenlehauer C; Fleury H; Heshmati F; Saragosti S; Letourneur F; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):19-27. PubMed ID: 8989423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.
    van Gemen B; van Beuningen R; Nabbe A; van Strijp D; Jurriaans S; Lens P; Kievits T
    J Virol Methods; 1994 Sep; 49(2):157-67. PubMed ID: 7822457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes.
    Gobbers E; Fransen K; Oosterlaken T; Janssens W; Heyndrickx L; Ivens T; Vereecken K; Schoones R; van de Wiel P; van der Groen G
    J Virol Methods; 1997 Jul; 66(2):293-301. PubMed ID: 9255740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.
    Beaumont T; Broersen S; van Nuenen A; Huisman HG; de Roda Husman AM; Heeney JL; Schuitemaker H
    J Virol; 2000 Sep; 74(17):7699-707. PubMed ID: 10933675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selective elimination of HIV-infected cells from peripheral blood in AIDS patients by the immunotoxin DAB389CD4.
    Martín-Serrano J; Folgueira L; Laín de Lera T; Pedraza MA; Lemichez E; Sánchez-Palomino S; Noriega AR; Boquet P; Alcamí J
    AIDS; 1998 May; 12(8):859-63. PubMed ID: 9631138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
    Zhang YJ; Fredriksson R; McKeating JA; Fenyö EM
    Virology; 1997 Nov; 238(2):254-64. PubMed ID: 9400598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.
    Lee EM; Chung HK; Livesay J; Suschak J; Finke L; Hudacik L; Galmin L; Bowen B; Markham P; Cristillo A; Pal R
    J Virol Methods; 2010 Feb; 163(2):287-94. PubMed ID: 19878696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells.
    Debiaggi M; Bruno R; Carlevari M; Achilli G; Emanuelli B; Cereda PM; Romero E; Filice G
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):287-96. PubMed ID: 7742042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type-1 mRNA splicing pattern in infected persons is determined by the proportion of newly infected cells.
    Vesanen M; Markowitz M; Cao Y; Ho DD; Saksela K
    Virology; 1997 Sep; 236(1):104-9. PubMed ID: 9299622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.
    Pugach P; Kuhmann SE; Taylor J; Marozsan AJ; Snyder A; Ketas T; Wolinsky SM; Korber BT; Moore JP
    Virology; 2004 Mar; 321(1):8-22. PubMed ID: 15033560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for rapid selection and deletion of HIV-1 subpopulations in vivo by V3-specific neutralizing antibody: a model of humoral-associated selection.
    Nara P; Smit L; Dunlop N; Hatch W; Merges M; Waters D; Kelliher J; Krone W; Goudsmit J
    Dev Biol Stand; 1990; 72():315-41. PubMed ID: 2282990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.